TECENTRIQ® is a cancer immunotherapy indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma. TECENTRIQ® is administered by intravenous infusion that can help reactivate the immune system so it can recognize cancer cells in the body.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.